Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis (ITD)
Primary Purpose
Intradialytic Hypotension, End Stage Renal Disease, Low Blood Pressure
Status
Terminated
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
ITD
Sham
Sponsored by
About this trial
This is an interventional treatment trial for Intradialytic Hypotension focused on measuring Hypotension during dialysis, End Stage Renal Disease, Decrease complications during dialysis, Low Blood Pressure
Eligibility Criteria
Inclusion Criteria:
- Subjects 8-18 years of age
- Subjects undergoing hemodialysis for ESRD
Exclusion Criteria:
- Subjects less than 8 years old or greater than 18 years old.
- Hemodialysis for indications other than ESRD.
- Current symptoms of chest pain, shortness of breath, fever, presence of dilated cardiomyopathy, unstable congestive heart failure, pulmonary hypertension, atrial fibrillation, hyperthyroidism, and aortic stenosis.
Sites / Locations
- The Children's Hospital of Philadelphia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Sham Device first, ITD next
ITD first, sham device next
Arm Description
Subjects will be randomized to recieve sham device first, ITD next after washout of 7 days.
Subjects will be randomized to receive ITD first, sham device next, after washout of 7 days.
Outcomes
Primary Outcome Measures
Fluid Removal
Fluid removed as percentage of dry body weight.
Secondary Outcome Measures
Extra Days to Achieve Target Dry Weight
Extra number of days required for hemodialysis/ultrafiltration to achieve dry body weight
Changes in Heart Rate and Blood Pressure Measured by a Non-invasive Cuff.
Full Information
NCT ID
NCT00576524
First Posted
December 17, 2007
Last Updated
January 22, 2013
Sponsor
Children's Hospital of Philadelphia
Collaborators
Advanced Circulatory Systems
1. Study Identification
Unique Protocol Identification Number
NCT00576524
Brief Title
Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis
Acronym
ITD
Official Title
Application of Impedance Threshold Device Technologies to Treat and Prevent Intradialytic Hypotension in Children Undergoing Hemodialysis
Study Type
Interventional
2. Study Status
Record Verification Date
January 2013
Overall Recruitment Status
Terminated
Why Stopped
Completion not feasible. THERE ARE NO RESULTS FROM THIS TRIAL
Study Start Date
September 2008 (undefined)
Primary Completion Date
February 2011 (Actual)
Study Completion Date
February 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Children's Hospital of Philadelphia
Collaborators
Advanced Circulatory Systems
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the application of the impedance threshold device during hemodialysis in children to optimize fluid removal, reduce the incidence of complications (such as cramps,vomiting and hypotension), and device tolerance.
Detailed Description
Effective fluid removal during hemodialysis is one of the biggest challenges in children with end-stage renal disease (ESRD). Generally, children do not tolerate having more than 3-4% of their body weight removed during each dialysis session thus necessitating multiple sessions each week to ensure effective renal replacement. Excessive fluid removal is often associated with nausea, vomiting, hypotension and cramps resulting in serious complications in patient care during and immediately after dialysis as well as reduced patient compliance. The development of novel therapies to increase the amount of fluid removed during each session without a corresponding increase in the incidence of complications is therefore very important to improve quality and compliance with hemodialysis; and eventually survival of children with ESRD. The purpose of this study is to evaluate the application of the impedance threshold device during hemodialysis in children to optimize fluid removal, reduce the incidence of complications (such as cramps,vomiting and hypotension), and device tolerance.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intradialytic Hypotension, End Stage Renal Disease, Low Blood Pressure
Keywords
Hypotension during dialysis, End Stage Renal Disease, Decrease complications during dialysis, Low Blood Pressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sham Device first, ITD next
Arm Type
Experimental
Arm Description
Subjects will be randomized to recieve sham device first, ITD next after washout of 7 days.
Arm Title
ITD first, sham device next
Arm Type
Experimental
Arm Description
Subjects will be randomized to receive ITD first, sham device next, after washout of 7 days.
Intervention Type
Device
Intervention Name(s)
ITD
Other Intervention Name(s)
ResQpod
Intervention Description
ITD will be applied for 30 minutes at a time with 10 minute breaks for the entire duration of hemodialysis on 2 separate occasions
Intervention Type
Device
Intervention Name(s)
Sham
Intervention Description
Sham will be applied for 30 minutes at a time with 10 minute breaks for the entire duration of hemodialysis on 2 separate occasions
Primary Outcome Measure Information:
Title
Fluid Removal
Description
Fluid removed as percentage of dry body weight.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Extra Days to Achieve Target Dry Weight
Description
Extra number of days required for hemodialysis/ultrafiltration to achieve dry body weight
Time Frame
6 weeks
Title
Changes in Heart Rate and Blood Pressure Measured by a Non-invasive Cuff.
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects 8-18 years of age
Subjects undergoing hemodialysis for ESRD
Exclusion Criteria:
Subjects less than 8 years old or greater than 18 years old.
Hemodialysis for indications other than ESRD.
Current symptoms of chest pain, shortness of breath, fever, presence of dilated cardiomyopathy, unstable congestive heart failure, pulmonary hypertension, atrial fibrillation, hyperthyroidism, and aortic stenosis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vijay Srinivasan, MD
Organizational Affiliation
Children's Hospital of Philadelphia
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Children's Hospital of Philadelphia
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis
We'll reach out to this number within 24 hrs